Androgen receptor signaling and mutations in prostate cancer - Wikidata - wikimedia - TriplyDB

Androgen receptor signaling and mutations in prostate cancer

Androgen receptor signaling and mutations in prostate cancer

http://www.wikidata.org/entity/Q34425907

about

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer Mechanisms of resistance in castration-resistant prostate cancer (CRPC)Anti-androgenic effects of flavonols in prostate cancer Targeting molecular resistance in castration-resistant prostate cancer Basal cell carcinoma of the prostate: clinicopathologic analysis of three cases and a review of the literature Molecular mechanisms of silibinin-mediated cancer chemoprevention with major emphasis on prostate cancer Evolving landscape and novel treatments in metastatic castrate-resistant prostate cancer Identification of a Novel Coregulator, SH3YL1, That Interacts With the Androgen Receptor N-Terminus.Androgen receptor splice variants and prostate cancer: From bench to bedside.Androgen receptor mutations and polymorphisms in African American prostate cancer.Serum/glucocorticoid-regulated kinase 1 expression in primary human prostate cancers.The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetes Protein interactome of muscle invasive bladder cancer.Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen.A profile of enzalutamide for the treatment of advanced castration resistant prostate cancer.Molecular physiology of SPAK and OSR1: two Ste20-related protein kinases regulating ion transport.The inhibitory effects of AR/miR-190a/YB-1 negative feedback loop on prostate cancer and underlying mechanism.Genetic and epigenetic changes in human prostate cancer Androgen pathway resistance in prostate cancer and therapeutic implications Regulators of gene expression as biomarkers for prostate cancer Androgen receptor splice variants are resistant to inhibitors of Hsp90 and FKBP52, which alter androgen receptor activity and expression Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.Food components and contaminants as (anti)androgenic molecules.Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles.Effects of 14 frequently used drugs on prostate-specific antigen expression in prostate cancer LNCaP cells.Mechanisms of persistent activation of the androgen receptor in CRPC: recent advances and future perspectives.Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective.Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.Progress in the mechanism and drug development of castration-resistant prostate cancer.Antiandrogens act as selective androgen receptor modulators at the proteome level in prostate cancer cells.Phytotherapeutic approach: a new hope for polycyclic aromatic hydrocarbons induced cellular disorders, autophagic and apoptotic cell death.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer Quantitative proteomic determination of diethylstilbestrol action on prostate cancer.A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.MicroRNA-185 suppresses proliferation, invasion, migration, and tumorigenicity of human prostate cancer cells through targeting androgen receptor.The Rec protein of HERV-K(HML-2) upregulates androgen receptor activity by binding to the human small glutamine-rich tetratricopeptide repeat protein (hSGT).

P2860

Q26739708-08CCA32A-95FE-4020-A738-EE70EC926F6E Q26750620-8AA51297-3DDC-422D-B262-E6E575183E5E Q26774221-F46BF320-3B07-4B67-AA80-5EB364FFD078 Q26777700-C216D2D8-5866-4E79-9F11-0B2FD7FF09EE Q26795445-8543416E-CAF8-4867-ABEE-4F4E43F7774E Q26849499-8994F147-1AA6-4F1F-9763-37F55F5693D2 Q26995304-44A0F07F-F38D-4AD1-9626-5ACC46820263 Q27010542-2039DDD6-BE05-4594-AEC1-87EE3B188ACC Q30009112-BF8ECC40-7B71-4E9D-B49E-C8BCDF3368E5 Q33567024-294C8584-8B40-4D59-AEAD-B8964CF87BAC Q33775730-4F58FAAE-4CA3-4044-B969-B4DCEED99EA6 Q33896203-8C5C0E21-DF93-40DC-9F6E-D284D97D1B5A Q34189517-7E71DA2D-F5F4-4BC6-BAB5-54D71C752163 Q34447630-D482F015-D060-4FB7-8B5A-F2A0E30C6D9B Q34876528-8FB03AB4-50BE-491E-BAE5-76E6C8C5E47D Q35485855-A32C7724-D98A-44F4-B169-0F1A9331DD6B Q35754996-833A84F6-9A66-43F5-858E-EF9ECBCBE237 Q35900778-DC72C463-17D0-4719-91C2-1A5C3EAE3339 Q36002634-66FDAA65-91C6-47E2-B8ED-DD87BEFA22C4 Q36022274-5C4FFB5C-A26E-40B8-94BC-8FEE52C51929 Q36416370-7AB64A0D-0C04-4770-916A-1FCEC7A5C637 Q36439912-86BFE45C-7725-489F-8E31-A0464042A329 Q36807948-54324C17-F3AA-4377-AF6A-2E09D777E99F Q37496652-10E1F67A-81B4-4030-92C8-A9747BA964C7 Q37508596-EC1AD119-4845-4240-9966-FDB4DF051555 Q37645540-45435C0A-9A97-489A-8BA6-8B783284FCB5 Q37709535-37919E7F-30C7-48EA-950E-E6CA53FE3868 Q37720026-CFF474A2-CF46-4E97-A215-FE2D1B6B27AC Q37947091-DFBF3E14-1030-4021-A6C6-F72D332AE1DC Q38060845-3C9DC5E5-9E9F-4373-B59A-57ED50C74D96 Q38260830-6F26DFED-092E-43FD-848C-AFF1E4468C35 Q38826609-A150913B-BD9A-4B09-AAD6-D60389077FEE Q38908290-98193CB4-C6EE-4666-9A69-07F85394CF37 Q39029632-734B02EC-7A06-4473-982A-CF4BA8027BCD Q39044222-8A73EB97-860E-49DA-8E01-3968A4465105 Q39152842-6F903E08-88E8-478A-A9CA-F11448343D77 Q39189586-3C2C3516-4190-4353-A755-210C793D303F Q39192814-7AFC5D52-0B84-4AD7-9FEA-E2C8F0252337 Q39192939-C7B917A3-CCDD-449A-9A56-AE1DA0F7A6C1 Q39325220-AE24A191-5F73-4455-BC89-6C7742D073DA

P2860

Androgen receptor signaling and mutations in prostate cancer

http://www.wikidata.org/entity/Q34425907

description

2010 nî lūn-bûn

@nan

2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Androgen receptor signaling and mutations in prostate cancer

@ast

Androgen receptor signaling and mutations in prostate cancer

@en

Androgen receptor signaling and mutations in prostate cancer

@nl

type

label

Androgen receptor signaling and mutations in prostate cancer

@ast

Androgen receptor signaling and mutations in prostate cancer

@en

Androgen receptor signaling and mutations in prostate cancer

@nl

prefLabel

Androgen receptor signaling and mutations in prostate cancer

@ast

Androgen receptor signaling and mutations in prostate cancer

@en

Androgen receptor signaling and mutations in prostate cancer

@nl

P1433

Q34425907-494325B3-FEFC-48FF-913B-BF1379BE4FCE

P1476

Q34425907-3F61CDCB-08C6-4059-A232-07E04C445F2A

P2093

Q34425907-6EA9A5C9-C36C-420B-8778-7D0A38FE29ED

P2860

Q34425907-01A3D7B9-7E51-4736-B3C4-2DC9171CAF18

Q34425907-01DEC96D-96F6-49C8-A819-90858CBE9050

Q34425907-034113A6-BAA1-4A4B-9661-403175A96100

Q34425907-0642BE13-5BFA-4EBC-888E-33E0A50262D1

Q34425907-088B3351-1282-47FB-B805-F12EEC7E671D

Q34425907-0CB6DF19-DE98-4670-A572-E1010F4CA8A8

Q34425907-0CE1BA05-0422-4DC1-A16B-DC39AF6A6789

Q34425907-0D0A6284-BD8E-451F-A8AA-37826CAEF4ED

Q34425907-10F53D8B-750E-4653-8303-FBCB0267866A

Q34425907-167BB17D-4AE1-4FD1-BDB9-529DD1088686

P304

Q34425907-7A29EFBE-312E-4E75-8E15-96A4C70397C0

P31

Q34425907-81DF268F-7CB3-4241-B15B-39F788D020C1

P356

Q34425907-9A369DC2-6648-4C0B-AA6B-35350617D3D5

P433

Q34425907-D391E12D-6A5E-4EB6-9A70-E87E1CC1C47F

P478

Q34425907-5EC0B570-995B-456D-8190-88FEEBDCF96F

P50

Q34425907-A27AC3A4-D681-47A3-90B7-3DC3B722690E

P577

Q34425907-23DD1A7A-11CF-4281-88B4-E628DDD64DDD

P5875

Q34425907-3F3B387F-6C86-49D8-8977-38579CF803DE

P698

Q34425907-15331C53-B6CE-4645-93F2-B216EEF1C32E

P932

Q34425907-BC76540F-7F56-4AFF-A088-0F2E91299E97

P356

P1433

Asian Journal of Andrology

P1476

Androgen receptor signaling and mutations in prostate cancer

@en

P2093

Shahriar Koochekpour

http://www.w3.org/2001/XMLSchema#string

P2860

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

Biological Actions of Androgens

Androgen receptor interactions with Oct-1 and Brn-1 are physically and functionally distinct

Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells

Recruitment of octamer transcription factors to DNA by glucocorticoid receptor.

A tale of three fingers: the family of mammalian Sp/XKLF transcription factors

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB

Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes

Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor

P304

639-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/AJA.2010.89

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45651121

http://www.w3.org/2001/XMLSchema#string

P698

20711217

http://www.w3.org/2001/XMLSchema#string

P932

3006239

http://www.w3.org/2001/XMLSchema#string